• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Nov 13, 2024 at 11:22: AM
via Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a continued appetite for these drugs.

article source
 




Top Bottom
Back
Quote